Publications by authors named "Anurag Relan"

Claim this Profile
C
Clinical and genetic findings of individuals tested using the navigateAPDS genetic testing program.
Emily Campbell, Jenny Garkaby, Julia Upton, Nami Park, Mike Samad, Anurag Relan

Ann Allergy Asthma Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piloting an automated query and scoring system to facilitate APDS patient identification from health systems.
Amy M FitzPatrick, Aaron T Chin, Sharon Nirenberg, Charlotte Cunningham-Rundles, Keith Sacco, Anurag Relan

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis.
V Koneti Rao, Anna Šedivá, Virgil A S H Dalm, Alessandro Plebani, Catharina Schuetz, Anurag Relan

Clin Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim analysis: Open-label extension study of leniolisib for patients with APDS.
V Koneti Rao, Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anurag Relan

J Allergy Clin Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome.
V Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anurag Relan

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of recombinant human C1 esterase inhibitor in children with hereditary angioedema.
Siobhán Hayes, Colm Farrell, Anurag Relan, John Anderson

Ann Allergy Asthma Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
Anna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, Milos Jesenak, Kinga Viktória Kőhalmi, Anurag Relan

World Allergy Organ J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.
Dumitru Moldovan, Jonathan A Bernstein, Roman Hakl, Grzegorz Porebski, Kimberly Poarch, Anurag Relan

J Allergy Clin Immunol Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
Jonathan A Bernstein, Christopher Tyson, Anurag Relan, Philippe Adams, Raf Magar

J Manag Care Spec Pharm· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
Avner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, Shmuel Kivity, Maria Klimaszewska-Rembiasz, Anurag Relan

Pediatr Allergy Immunol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
James W Baker, Jonathan A Bernstein, Joseph R Harper, Anurag Relan, Marc A Riedl

Allergy Asthma Proc· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply.
Marc A Riedl, Anurag Relan, Joseph R Harper, Marco Cicardi

Lancet· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
James W Baker, Avner Reshef, Dumitru Moldovan, Joseph R Harper, Anurag Relan

J Allergy Clin Immunol Pract· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
H Henry Li, Avner Reshef, James W Baker, Joseph R Harper, Anurag Relan

Allergy Asthma Proc· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Marc A Riedl, H Henry Li, Marco Cicardi, Joseph R Harper, Anurag Relan

Allergy Asthma Proc· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
Marc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, James Baker, William H Yang, Anurag Relan

Lancet· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
Jonathan A Bernstein, Anurag Relan, Joseph R Harper, Marc Riedl

Ann Allergy Asthma Immunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C1 Inhibitor Limits Organ Injury and Prolongs Survival in Swine Subjected to Battlefield Simulated Injury.
James C Campbell, Yansong Li, Edwin van Amersfoort, Anurag Relan, Michael Dubick

Shock· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process.
Zonne L M Hofman, Anurag Relan, Sacha Zeerleder, Christian Drouet, Bruce Zuraw

J Allergy Clin Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk.
Mignon T van den Elzen, Harmieke van Os-Medendorp, Heike Röckmann-Helmbach, Els van Hoffen, Ans F M Lebens, Anurag Relan

J Allergy Clin Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary Angioedema Attacks: Local Swelling at Multiple Sites.
Zonne L M Hofman, Anurag Relan, C Erik Hack

Clin Rev Allergy Immunol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
H Henry Li, Dumitru Moldovan, Jonathan A Bernstein, Avner Reshef, Gregor Porebski, Anurag Relan

J Allergy Clin Immunol Pract· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
Marc A Riedl, Jonathan A Bernstein, Henry Li, Avner Reshef, William Lumry, Anurag Relan

Ann Allergy Asthma Immunol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema.
Colm Farrell, Siobhan Hayes, Anurag Relan, Edwin S van Amersfoort, Rienk Pijpstra

Br J Clin Pharmacol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
Marc A Riedl, Robyn J Levy, Daniel Suez, Richard F Lockey, James W Baker, Anurag Relan

Ann Allergy Asthma Immunol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis